These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1131 related items for PubMed ID: 17446524

  • 1. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F, Catalano C, Padula S, Roselli A, Dominelli V, Cagioli S, Kirchin MA, Pirovano G, Passariello R.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [Abstract] [Full Text] [Related]

  • 3. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Pediconi F, Catalano C, Occhiato R, Venditti F, Fraioli F, Napoli A, Kirchin MA, Passariello R.
    Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
    [Abstract] [Full Text] [Related]

  • 4. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [Abstract] [Full Text] [Related]

  • 5. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C.
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [Abstract] [Full Text] [Related]

  • 6. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA.
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [Abstract] [Full Text] [Related]

  • 7. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F, Venditti F, Padula S, Roselli A, Moriconi E, Giacomelli L, Catalano C, Passariello R.
    Radiol Med; 2005 Jun; 110(1-2):61-8. PubMed ID: 16163140
    [Abstract] [Full Text] [Related]

  • 8. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L, Morana G, Kirchin MA, Schneider G.
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [Abstract] [Full Text] [Related]

  • 9. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
    Carbonaro LA, Verardi N, Di Leo G, Sardanelli F.
    Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
    [Abstract] [Full Text] [Related]

  • 10. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, Pronio A, Kirchin MA, Passariello R.
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [Abstract] [Full Text] [Related]

  • 11. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T, Yuen S, Kasami M, Uchida Y.
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [Abstract] [Full Text] [Related]

  • 12. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA.
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [Abstract] [Full Text] [Related]

  • 13. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 14. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
    Gilbert FJ, van den Bosch HC, Petrillo A, Siegmann K, Heverhagen JT, Panizza P, Gehl HB, Pediconi F, Diekmann F, Peng WJ, Ma L, Sardanelli F, Belli P, Corcione S, Zechmann CM, Faivre-Pierret M, Martincich L.
    J Magn Reson Imaging; 2014 May; 39(5):1272-86. PubMed ID: 25006633
    [Abstract] [Full Text] [Related]

  • 15. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, Bazzocchi M.
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [Abstract] [Full Text] [Related]

  • 16. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A.
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [Abstract] [Full Text] [Related]

  • 17. Normal breast parenchyma: contrast enhancement kinetics at dynamic MR mammography--influence of anthropometric measures and menopausal status.
    Hegenscheid K, Schmidt CO, Seipel R, Laqua R, Ohlinger R, Kühn JP, Hosten N, Puls R.
    Radiology; 2013 Jan; 266(1):72-80. PubMed ID: 23023963
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
    Friedlander LC, Roth SO, Gavenonis SC.
    Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
    [Abstract] [Full Text] [Related]

  • 20. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K, Schrading S, Hansen NL, Barabasch A, Kuhl CK.
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.